Community Healthcare Trust Incorporated CHCT NYSE · Real estate · United States
$14.73 -1.87% -$0.28
Summary
63 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 10 years in a row.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 32 USD is left as free cash.
- Revenue grew by 7.5% a year over the last 3 years.
What to watch
- Earnings per share fell by 54% a year over the last 3 years.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 9.9% a year over 5 years. Over the last 3 years it grew by 7.5% a year. Earnings per share fell by 54% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 36 USD
- Sales and administration 32 USD
- Taxes and other 14 USD
- Net profit 18 USD
Net profit, industry median (REIT - Healthcare Facilities) 15 USD
Out of every 100 USD of revenue, 18 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 14.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 10.98%
- Paid out of profit
- 207%
- Raised in a row
- 10 years
You receive $1.62 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 7
- Hold 8
- Sell 1
Today's price within the analysts' price targets
The average target of $17 is 15% above today's price. 44% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2018By product
- Real Estate 100%
By region
The company reports no revenue by region.
Real Estate brings in 100% of revenue.
Segments in detail